『March 2018 Drug Price Notice』

 

1. Newly listed item on March 1, 2018 (scheduled to be released in April)

product code

Product Name

Ingredient content

drug price

Remarks

648104031

Dexidifen syrup (dexibuprofen)_(6g/500mL)

Dexibuprofen

12 mg/mL

29 won/mL

Salary recognition from March 1, 2018

 

2. Items deleted on March 1, 2018 (2017 unproduced/expired drug benefit list)

product code

Product Name

product code

Product Name

648101380

Aspen S tablet (acetaminophen Zephyr tablet)_(0.325g/1 tablet)

648102930

Irbetan tablet 300 mg

(Ibesartan)_(0.3g/1 tablet)

648100730

Mesulan tablets (nimesulide)

(Export name: DANKALTab.)_(0.1g/1 tablet)

648103122

Phenium syrup (Pelargonium sidoides 11% ethanol extract (1→8~10) and glycerin mixture (8:2))_(1.5444g/9mL)

648101210

Cilapril tablets (Cilazapril)

(2.5mg/1 tablet)

648100670

Mybio Capsule (Saccharomyces boulardii) (Export name: FLORINA)_(0.113g/1 capsule)

648101820

Cardil tablet 1 mg

(Doxazosin mesylate)_(1.213mg/1 tablet)

648100340

Dymit tablets 250 milligrams

(Metformin hydrochloride)_(0.25g/1 tablet)

648101810

Cardil tablets (doxazosin mesylate)

(2.43mg/1 tablet)

648101030

For Cetiam intradermal reaction

(Cefotiam hydrochloride)_(0.3mg/bottle)

648103010

Irbetan tablets 150 mg

(Ibesartan)_(0.15g/1 tablet)

648102010

Kefloxin tablets

(Ofloxacin)_(0.1g/1 tablet)

□ Ministry of Health and Welfare Notice No. 2018-26

Article 22 (1) of the Enforcement Decree of the National Health Insurance Act and “Standards for National Health Insurance Nursing Care Benefits”

The “Pharmaceutical Benefit List and Benefit Maximum Amount Table” pursuant to Article 8, Paragraph 2 of the “Rules” has been revised and announced.